Clinical Importance of FNDC-5 and Selectin-E mRNA Expression Among Type 2 Diabetics with and without Obesity

References

• Hu FB. Obesity Epidemiology. Oxford; New York: Oxford University Press; 2008:498.
   Google Scholar
• Reinehr T, Elfers C, Lass N, Roth CL. Irisin and its relation to insulin resistance and puberty in obese children: a longitudinal analysis. J Clin Endocrinol Metab. 2015;100:2123–2130. doi:10.1210/jc.2015-1208
   PubMed Web of Science ®Google Scholar
• Chen N, Li Q, Liu J, Jia S. Irisin, an Exercise-induced myokine as a metabolic regulator: an updated narrative review. Diabetes Metab Res Rev. 2016;32:51–59. doi:10.1002/dmrr.2660
   PubMed Web of Science ®Google Scholar
• Perakakis N, Triantafyllou GA, Fernandez-Real JM, et al. Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol. 2017;13:324–337. doi:10.1038/nrendo.2016.221
   PubMed Web of Science ®Google Scholar
• Park KH, Zaichenko L, Brinkoetter M, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013;98:4899–4907. doi:10.1210/jc.2013-2373
   PubMed Web of Science ®Google Scholar
• Crujeiras AB, Zulet MA, Lopez-Legarrea P, et al. Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients. Metabolism. 2014;63:520–531. doi:10.1016/j.metabol.2013.12.007
   PubMed Web of Science ®Google Scholar
• McEver RP. Selectins: initiators of leucocyte adhesion and signalling at the vascular wall. Cardiovasc Res. 2015;107:331–339. doi:10.1093/cvr/cvv154
   PubMed Web of Science ®Google Scholar
• Yago T, Shao B, Miner JJ, et al. E-selectin engages PSGL-1 and CD44 through a common signaling pathway to induce integrin αLβ2-mediated slow leukocyte rolling. Blood. 2010;116:485–494. doi:10.1182/blood-2009-12-259556
   PubMed Web of Science ®Google Scholar
• Antoine M, Tag CG, Gressner AM, Hellerbrand C, Kiefer P. Expression of E-selectin ligand-1 (CFR/ESL-1) on hepatic stel- late cells: implications for leukocyte extravasation and liver metastasis. Oncol Rep. 2009;21(2):357–362.
   Web of Science ®Google Scholar
• Vestweber D, Blanks JE. Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev. 1999;79(1):181–213. doi:10.1152/physrev.1999.79.1.181
   PubMed Web of Science ®Google Scholar
• Zarbock A, Lowell CA, Ley K. Spleen tyrosine kinase Syk is necessary for E-selectin-induced aLb2 integrin-mediated rolling on intercellular adhesion molecule-1. Immunity. 2007;26:773–783. doi:10.1016/j.immuni.2007.04.011
   PubMed Web of Science ®Google Scholar
• Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22(4):477–501. doi:10.1210/edrv.22.4.0437
   PubMed Web of Science ®Google Scholar
• Finkelstein JL, Layden AJ, Stover PJ. Vitamin B-12 and Perinatal Health. Adv Nutr. 2015;6(5):552–563. doi:10.3945/an.115.008201
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome–a new world-wide definition. A consensus statement from the international diabetes federation. Diabet. Med. 2006;23(5):469–480. doi:10.1111/j.1464-5491.2006.01858.x
   PubMed Web of Science ®Google Scholar
• Shrivastava U, Misra A, Mohan V, Unnikrishnan R, Bachani D. Obesity, diabetes and cardiovascular diseases in India: public health challenges. Curr Diabetes Rev. 2017;13(1):65–80. doi:10.2174/1573399812666160805153328
   PubMed Web of Science ®Google Scholar
• Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118(11):1723–1735. doi:10.1161/CIRCRESAHA.115.306825
   PubMed Web of Science ®Google Scholar
• Bonfante IL, Chacon-Mikahil MP, Brunelli DT, et al. Combined training, FNDC5/irisin levels and metabolic markers in obese men: a randomised controlled trial. Eur J Sport Sci. 2017;17(5):629–637. doi:10.1080/17461391.2017.1296025
   PubMed Web of Science ®Google Scholar
• Lecker SH, Zavin A, Cao P, et al. Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure. Circ Heart Fail. 2012;5(6):812–818. doi:10.1161/CIRCHEARTFAILURE.112.969543
   Web of Science ®Google Scholar
• Xiong XQ, Geng Z, Zhou B, et al. FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity. Metabolism. 2018;83:31–41. doi:10.1016/j.metabol.2018.01.013
   PubMed Web of Science ®Google Scholar
• Matsuo Y, Gleitsmann K, Mangner N, et al. Fibronectin type III domain containing 5 expression in skeletal muscle in chronic heart failure-relevance of inflammatory cytokines. J Cachexia Sarcopenia Muscle. 2015;6(1):62–72. doi:10.1002/jcsm.12006
   Web of Science ®Google Scholar
• Duan H, Ma B, Ma X, et al. Anti-diabetic activity of recombinant irisin in STZ-induced insulin-deficient diabetic mice. Int J Biol Macromol. 2016;84:457–463. doi:10.1016/j.ijbiomac.2015.12.049
   PubMed Web of Science ®Google Scholar
• Moreno-Navarrete JM, Ortega F, Serrano M, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013;98(4):E769–E778. doi:10.1210/jc.2012-2749
   PubMed Web of Science ®Google Scholar
• Jiang S, Piao L, Ma EB, Ha H, Huh JY. Associations of circulating irisin with FNDC5 expression in fat and muscle in Type 1 and Type 2 diabetic mice. Biomolecules. 2021;11(2):322. doi:10.3390/biom11020322
   PubMed Web of Science ®Google Scholar
• Chen TC, Chien SJ, Kuo HC, et al. High glucose-treated macrophages augment E-selectin expression in endothelial cells. J Biol Chem. 2011;286(29):25564–25573. doi:10.1074/jbc.M111.230540
   Web of Science ®Google Scholar
• Knudsen ST, Foss CH, Poulsen PL, et al. E-selectin-inducing activity in plasma from type 2 diabetic patients with maculopathy. Am J Physiol Endocrinol Metab. 2003;284(1):E1–E6. doi:10.1152/ajpendo.00198.2002
   Web of Science ®Google Scholar
• Abu-Amero KK, Al-Mohanna F, Al-Boudari OM, Mohamed GH, Dzimiri N. The interactive role of type 2 diabetes mellitus and E-selectin S128R mutation on susceptibility to coronary heart disease. BMC Med Genet. 2007;8:35. doi:10.1186/1471-2350-8-35
   Web of Science ®Google Scholar
• Hamilton SJ, Watts GF. Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment. Rev Diabet Stud. 2013;10(2–3):133–156. doi:10.1900/RDS.2013.10.133
   PubMedGoogle Scholar
• Rana KS, Pararasa C, Afzal I, et al. Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels. Cardiovasc Diabetol. 2017;16(1):147. doi:10.1186/s12933-017-0627-2
   PubMed Web of Science ®Google Scholar